Kristine Peterson

Insider Reports History

Location
Mystic, CT
Signature
By: /s/ James Kastenmayer, Attorney-in-Fact for Kristine Peterson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristine Peterson:

Company Role Class Num Shares Value Price $ Report Date Ownership
AMARIN CORP PLC\UK Director Stock Option (Right to Buy) 115,919 $125,193 $1.08 27 Jun 2022 Direct
ImmunoGen, Inc. Director Deferred Share Unit 0 $0 $29.30 12 Feb 2024 Direct
ImmunoGen, Inc. Director Restricted Stock Unit 0 $0 $29.30 12 Feb 2024 Direct
AMARIN CORP PLC\UK Director Restricted Stock Units 93,750 27 Jun 2022 Direct
Immunocore Holdings plc Director Share Option (Right to Buy) 26,198 15 May 2025 Direct
ENANTA PHARMACEUTICALS INC Director Stock Option (right to buy) 15,700 13 Mar 2025 Direct
ArriVent BioPharma, Inc. Director Non-Qualified Stock Option (right to buy) 15,502 18 Jun 2025 Direct
ImmunoGen, Inc. Director Common Stock 0 $29.64 30 Nov 2023 Direct
ImmunoGen, Inc. Director Stock Option (Right to Buy) 0 $5.19 12 Feb 2024 Direct
Paratek Pharmaceuticals, Inc. Director Common Stock 0 $2.20 21 Sep 2023 Direct
Paratek Pharmaceuticals, Inc. Director Stock option (right to buy) 0 21 Sep 2023 Direct

Insider Reports Filed by Kristine Peterson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVBP ArriVent BioPharma, Inc. 18 Jun 2025 1 $0 4 Director 20 Jun 2025, 19:32
IMCR Immunocore Holdings plc 15 May 2025 1 $0 4 Director 19 May 2025, 16:15
ENTA ENANTA PHARMACEUTICALS INC 13 Mar 2025 1 $0 4 Director 14 Mar 2025, 17:43
IMCR Immunocore Holdings plc 23 May 2024 1 $0 4 Director 28 May 2024, 16:15
AVBP ArriVent Biopharma, Inc. 22 Apr 2024 1 $0 4 Director 23 Apr 2024, 16:06
AVBP ArriVent Biopharma, Inc. 20 Apr 2024 0 $0 3 Director 23 Apr 2024, 16:05
ENTA ENANTA PHARMACEUTICALS INC 06 Mar 2024 1 $0 4 Director 08 Mar 2024, 17:23
/report/000110465924014718-peterson-kristine-2024-02-12 ImmunoGen, Inc. 12 Feb 2024 10 $0 4 Director 12 Feb 2024, 16:48
IMCR Immunocore Holdings plc 02 Jan 2024 0 $0 3 Director 02 Jan 2024, 16:54
/report/000141588923015908-peterson-kristine-2023-11-30 ImmunoGen, Inc. 30 Nov 2023 5 -$346,300 4 Director 05 Dec 2023, 21:06
/report/000089924323019363-peterson-kristine-2023-09-21 Paratek Pharmaceuticals, Inc. 21 Sep 2023 8 $0 4 Director 21 Sep 2023, 14:21
/report/000141588923013292-peterson-kristine-2023-09-13 ImmunoGen, Inc. 13 Sep 2023 3 -$13,800 4 Director 14 Sep 2023, 18:31
/report/000141588923009948-peterson-kristine-2023-06-14 ImmunoGen, Inc. 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:45
ENTA ENANTA PHARMACEUTICALS INC 02 Mar 2023 1 $0 4 Director 06 Mar 2023, 16:19
/report/000090445423000107-peterson-kristine-2023-02-08 Paratek Pharmaceuticals, Inc. 08 Feb 2023 1 $0 4 Director 09 Feb 2023, 20:43
AMRN AMARIN CORP PLC\UK 27 Jun 2022 2 $0 4 Director 29 Jun 2022, 20:06
/report/000141588922006721-peterson-kristine-2022-06-15 ImmunoGen, Inc. 15 Jun 2022 2 +$148,280 4 Director 17 Jun 2022, 16:13
ENTA ENANTA PHARMACEUTICALS INC 03 Mar 2022 1 $0 4 Director 07 Mar 2022, 17:46
/report/000090445422000169-peterson-kristine-2022-02-16 Paratek Pharmaceuticals, Inc. 16 Feb 2022 1 $0 4 Director 18 Feb 2022, 16:27
/report/000117911021006814-peterson-kristine-2021-06-16 ImmunoGen, Inc. 16 Jun 2021 2 +$297,880 4 Director 17 Jun 2021, 16:22
AMRN AMARIN CORP PLC\UK 14 Jun 2021 2 $0 4 Director 16 Jun 2021, 20:04